Phospholipids are essential structural and functional components of hepatocellular membranes. Therefore, a bromobenzene (BB)- and CCl4-dependent reduction in the steady-state (equilibrium between production and degradation) level of hepatocellular phospholipids may represent a critical event in BB- and CCl4-induced hepatocyte injury. The primary objective of this project is to determine if4BB- and CCl4-dependent liver cell injury and death are related to the alterations that exposure to these agents in vivo and in vitro produce in the content of hepatocellular phospholipids. This goal will be achieved by exposing hepatocyte monolayers and intact animals (rats) to BB and CCl4 and correlating changes in the degfradation, formation and content of membrane phospho lipids with the functional (release of intracellular K plus and aminotransferase enzymes, etc.) and structural (morphological changes assessed by light and electron microscopy) integrity of hepatocytes and hepatocellular membranes. Hopefully, these studies will establish that: 1) a rapid (1 min), Ca2+-dependent, BB- and CCl4-induced rise in a phospholipase C mediated reduction in hepatocellular phospholipids represents a key event in hepatotoxin-induced hepatocyte injury; 2) the severity (reversible or irreversible) of BB- and CCl4-dependent hepatocyte damage is directly related to the degree of hepatocellular phospholipid degradation and the ability of cells to synthesize new phospholipids (repair injured membranes). These studies will also increase our knowledge of those factors that regulate hepatocellular phospholipid degradation, biosynthesis and content and this information may be fundamentally important in understanding the pathogenesis of hepatotoxin-induced liver cell injury and death.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK031115-04
Application #
3229879
Study Section
Toxicology Study Section (TOX)
Project Start
1983-02-01
Project End
1988-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Kim, Yoonkyung; Klutz, Athena M; Jacobson, Kenneth A (2008) Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. Bioconjug Chem 19:1660-72
Ivanov, Andrei A; Jacobson, Kenneth A (2008) Molecular modeling of a PAMAM-CGS21680 dendrimer bound to an A2A adenosine receptor homodimer. Bioorg Med Chem Lett 18:4312-5
Palaniappan, Krishnan K; Gao, Zhan-Guo; Ivanov, Andrei A et al. (2007) Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides. Biochemistry 46:7437-48
Jacobson, Kenneth A; Gao, Zhan-Guo; Liang, Bruce T (2007) Neoceptors: reengineering GPCRs to recognize tailored ligands. Trends Pharmacol Sci 28:111-6
Gao, Zhan-Guo; Duong, Heng T; Sonina, Tatiana et al. (2006) Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists. J Med Chem 49:2689-702
Van Rompaey, Philippe; Jacobson, Kenneth A; Gross, Ariel S et al. (2005) Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety. Bioorg Med Chem 13:973-83
Besada, Pedro; Mamedova, Liaman; Thomas, Craig J et al. (2005) Design and synthesis of new bicyclic diketopiperazines as scaffolds for receptor probes of structurally diverse functionality. Org Biomol Chem 3:2016-25
Jacobson, Kenneth A; Gao, Zhan-Guo; Tchilibon, Susanna et al. (2005) Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection. J Med Chem 48:8103-7
Jacobson, Kenneth A; Ohno, Michihiro; Duong, Heng T et al. (2005) A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists. Chem Biol 12:237-47
Lamb, R G; Koch, J C; Snyder, J W et al. (1994) An in vitro model of ethanol-dependent liver cell injury. Hepatology 19:174-82

Showing the most recent 10 out of 14 publications